Endpoints News | August 2, 2019:
Mickey Mikitani made it clear, over the three years he’s backed the San Diego startup Aspyrian Therapeutics, that he’s ready to bet a fortune of his massive wealth — estimated at $6.7 billion — on its photoimmunotherapy tech. The e-tail billionaire got involved early in the $40 million Series A, provided the lion’s share for the subsequent rounds totaling $284 million, took charge first as chairman then as CEO, and gradually integrated the biotech’s brand entirely into his Rakuten empire.
